These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 4565817

  • 1. Single and combination nonhormonal chemotherapy in breast cancer.
    Carter SK.
    Cancer; 1972 Dec; 30(6):1543-55. PubMed ID: 4565817
    [No Abstract] [Full Text] [Related]

  • 2. Single-agent therapy for Hodgkin's disease.
    Carter SK, Livingston RB.
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract] [Full Text] [Related]

  • 3. [Current status of chemotherapy of malignant tumors of the ovaries].
    Nechaeva ID.
    Vopr Onkol; 1968 Mar; 14(6):108-22. PubMed ID: 4972640
    [No Abstract] [Full Text] [Related]

  • 4. Cytotoxic agents in the treatment of malignant disease.
    Br Med J; 1968 Nov 16; 4(5628):438-9. PubMed ID: 4972069
    [No Abstract] [Full Text] [Related]

  • 5. [Effects, administration forms and dosage of cytostatic agents in the treatment of gynecologic tumors. (Review)].
    Huber R.
    Zentralbl Gynakol; 1967 Sep 23; 89(38):1377-83. PubMed ID: 4873356
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy of solid tumors. Recent advances.
    Livingston RB.
    Postgrad Med; 1976 Feb 23; 59(2):121-6. PubMed ID: 175357
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Proceedings: Chemotherapy of adenocarcinoma of the kidney.
    Talley RW.
    Cancer; 1973 Nov 23; 32(5):1062-5. PubMed ID: 4757900
    [No Abstract] [Full Text] [Related]

  • 10. [Chemotherapy of cancer. Hints for continuing medical education].
    Berndt H, Rieche K.
    Z Arztl Fortbild (Jena); 1974 Feb 15; 68(4):193-5. PubMed ID: 4838434
    [No Abstract] [Full Text] [Related]

  • 11. [Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].
    Pipino G, Germiniani R, Lavorato F.
    Minerva Med; 1977 Mar 17; 68(13):835-7. PubMed ID: 321990
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer chemotherapy: perioperative considerations in breast reconstruction.
    Gargan TJ, Come SE, Satwicz PR.
    Plast Reconstr Surg; 1985 Mar 17; 75(3):430-4. PubMed ID: 3919414
    [No Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK.
    Postgrad Med; 1985 Jan 17; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Chemotherapy of breast cancer].
    Tomin R.
    Med Pregl; 1969 Jan 17; 22(1):43-6. PubMed ID: 5195826
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemotherapy of solid tumors.
    Talley RW.
    Postgrad Med; 1970 Nov 17; 48(5):182-9. PubMed ID: 5478746
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M, Snel S, Havsteen H, Dombernowsky P, Mouridsen HT.
    Cancer Treat Rep; 1980 Nov 17; 64(4-5):635-7. PubMed ID: 7000346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.